Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer with Hepatic Metastases”

424 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 424 results

Testing effectiveness (Phase 2)UnknownNCT03803436
What this trial is testing

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Who this might be right for
Liver MetastasesColorectal Cancer MetastaticLiver Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Not applicableLooking for participantsNCT02864485
What this trial is testing

Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
University Health Network, Toronto 20
Large-scale testing (Phase 3)UnknownNCT04509635
What this trial is testing

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal CancerLiver MetastasesCetuximab
Fudan University 50
Testing effectiveness (Phase 2)Study completedNCT02195011
What this trial is testing

Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases

Who this might be right for
Colorectal Neoplasms
SCRI Development Innovations, LLC 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940546
What this trial is testing

Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in PMMR/MSS CRLM Patients

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Study completedNCT00068068
What this trial is testing

Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases

Who this might be right for
Liver MetastasisColorectal NeoplasmsLiver Neoplasms+1 more
Light Sciences LLC 25
Testing effectiveness (Phase 2)Study completedNCT00645710
What this trial is testing

Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery

Who this might be right for
Liver MetastasesRecurrent Colon CancerRecurrent Rectal Cancer+2 more
City of Hope Medical Center 16
Early research (Phase 1)Study completedNCT00001576
What this trial is testing

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Who this might be right for
Colorectal NeoplasmLiver NeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)UnknownNCT00997685
What this trial is testing

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

Who this might be right for
Potentially Resectable Liver Metastasis From CRCColorectal Cancer
Guangdong Provincial People's Hospital 110
Large-scale testing (Phase 3)Looking for participantsNCT06280495
What this trial is testing

Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients

Who this might be right for
Colorectal CancerLiver Metastases
Sun Yat-sen University 156
Very early researchEnded earlyNCT00835679
What this trial is testing

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Early research (Phase 1)Ended earlyNCT02110953
What this trial is testing

Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+8 more
Fox Chase Cancer Center 2
Testing effectiveness (Phase 2)UnknownNCT05314101
What this trial is testing

TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer

Who this might be right for
ImmunotherapyColorectal Cancer
Fujian Cancer Hospital 25
Testing effectiveness (Phase 2)Study completedNCT02015754
What this trial is testing

Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal Cancer
Yale University 14
Not applicableStudy completedNCT01318239
What this trial is testing

Perfusion and Diffusion Magnetic Resonance Imaging, and Phosphorylation of Circulation Endothelial Cells to Determine Anti-anogenic Effect of Chemotherapeutic Regimens in Colorectal Liver Metastasis Patients

Who this might be right for
Colorectal Cancer
Yonsei University 37
Testing effectiveness (Phase 2)Looking for participantsNCT06225843
What this trial is testing

Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis

Who this might be right for
Metastatic Colorectal Cancer
Alethia Biotherapeutics 17
Testing effectiveness (Phase 2)Study completedNCT00511862
What this trial is testing

TheraSphere for the Treatment of Liver Metastases

Who this might be right for
Colorectal CancerCarcinoma, NeuroendocrineNeoplasm Metastasis
Boston Scientific Corporation 151
Not applicableUnknownNCT04870879
What this trial is testing

Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors

Who this might be right for
Colorectal Liver MetastasesColorectal AdenocarcinomaUnresectable Malignant Neoplasm
Azienda Ospedaliera di Padova 18
Load More Results